ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CEL Celadon Pharmaceuticals Plc

100.00
2.00 (2.04%)
01 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Celadon Pharmaceuticals Plc LSE:CEL London Ordinary Share GB00BDQYGP38 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  2.00 2.04% 100.00 98.00 105.00 101.50 98.00 98.00 73,885 16:35:13
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Investment Advice 24k -17.01M -0.2722 -3.73 63.41M
Celadon Pharmaceuticals Plc is listed in the Investment Advice sector of the London Stock Exchange with ticker CEL. The last closing price for Celadon Pharmaceuticals was 98p. Over the last year, Celadon Pharmaceuticals shares have traded in a share price range of 77.50p to 180.00p.

Celadon Pharmaceuticals currently has 62,469,773 shares in issue. The market capitalisation of Celadon Pharmaceuticals is £63.41 million. Celadon Pharmaceuticals has a price to earnings ratio (PE ratio) of -3.73.

Celadon Pharmaceuticals Share Discussion Threads

Showing 6401 to 6424 of 6825 messages
Chat Pages: Latest  261  260  259  258  257  256  255  254  253  252  251  250  Older
DateSubjectAuthorDiscuss
24/6/2009
08:32
otherwise very solid good cost control which is what we need in current environment
dpeach
24/6/2009
08:32
Boad our divi maybe a T/O by NAV ;-)

IVT i think JLC mentioned this previously, interesting to see how first 3 months this year gone...

dpeach
24/6/2009
08:26
Verger - Underlying eps actually better than that figure which included amortisation of intangibles:-
"EPS adjusted for amortisation of intangible assets increased 25.1% to 44.57 cents per share (2008: 35.62 cents per share)"
The control of costs are particularly impressive.

However, there are some negatives.
First, the headline figures exclude the operating loss and termination cost of the disontinued operation.
Secondly, the figures for IVT are the poorest of the three divisions casting some doubt on the acquisition decision although synergies and cross-selling opportunities may outweigh this negative.
Finally, in my very brief scan I saw no mention of a dividend.

boadicea
24/6/2009
08:10
The fall in In Vitro Technologies revenues is a bit of a shocker, although they go onto say that they think they will recover
daz
24/6/2009
08:02
Pre-opening, share price down 1p, opening up 1p. Fair to say Market undecided. I wonder what NAV make of the results; will they be buying more?
verger
24/6/2009
07:15
Well, I like the results! EPS 41.88 cents. How does that compare with forecasts?
verger
23/6/2009
17:44
where from here then?, chart still looks good, results tomorrow.........
dpeach
19/6/2009
21:41
i think theres 30p to be made here quite quickly, i'm in for an initial £5k worth monday a.m. Shame about the dividend or lack of it thats seems to be the only negative.
davidwilkin
16/6/2009
11:52
Hopefully a rise from up-channel support.
If so then the recent trend is intact.
Flow

go with the flow
15/6/2009
11:48
last week on the 10th June a net 13500 bought and gained .5p, me thinks the trees shaking
dpeach
15/6/2009
10:57
dropped 5% on the sale of only 15,000 shares, low volume...
dpeach
15/6/2009
10:04
or not...ouch
dpeach
10/6/2009
10:53
upppola.... 2 weeks to the day to go probably going to see T trades coming through
dpeach
08/6/2009
08:48
well at least it's consistent
dpeach
04/6/2009
21:29
thanks CWA1 - and the dollar has noticeably strengthened (of late) from its recent low points vis a vis the £ while we await these (yes) long-awaited results...as you say, dpeach, exciting times, indeed....
sll
04/6/2009
18:37
wow that was an exciting day ;-)
(compared to recent times)

dpeach
30/5/2009
17:54
thank you!
verger
29/5/2009
12:26
Celsis will announce its preliminary results for the year ended 31 March 2009, on Wednesday 24 June 2009. There will be a presentation to analysts on the day at 9.30am, held at Financial Dynamics, Holborn Gate, 26 Southampton Buildings, London, WC2A 1PB.
cwa1
29/5/2009
12:24
Greetings all. Have we been given a date in June for the annual resuls?
verger
19/5/2009
12:31
Tight spread.
verger
18/5/2009
16:43
Jeremy Barnes brings with him a wealth of corporate finance experience, which will provide very valuable knowledge for our business - in the autumn ;-?
dpeach
15/5/2009
20:20
"Jeremy Barnes brings with him a wealth of corporate finance experience, which will provide very valuable knowledge for our business".

Presumably it helps to have a few heavyweight contacts when it comes to M&A activities and deciding what to do with all the cash that they expect to generate. He might also help in getting board to focus on getting reinvested profits to produce higher returns.

bookworm1
12/5/2009
16:59
Yep.
Also 200p is quite a psychological barrier.
Reckon your 230p prediction looks highly attainable in the short term.
Flow

go with the flow
12/5/2009
15:30
Flow, indeed, I think his target was 200p short term wasn't it?
dpeach
Chat Pages: Latest  261  260  259  258  257  256  255  254  253  252  251  250  Older

Your Recent History

Delayed Upgrade Clock